UY27766A1 - COMBINATION OF INSULIN AND A THIAZOLIDINDIONA DERIVATIVE AND USE OF THE SAME TO TREAT DIABETES - Google Patents

COMBINATION OF INSULIN AND A THIAZOLIDINDIONA DERIVATIVE AND USE OF THE SAME TO TREAT DIABETES

Info

Publication number
UY27766A1
UY27766A1 UY27766A UY27766A UY27766A1 UY 27766 A1 UY27766 A1 UY 27766A1 UY 27766 A UY27766 A UY 27766A UY 27766 A UY27766 A UY 27766A UY 27766 A1 UY27766 A1 UY 27766A1
Authority
UY
Uruguay
Prior art keywords
derivative
combination
thiazolidindiona
insulin
same
Prior art date
Application number
UY27766A
Other languages
Spanish (es)
Inventor
Mesangeau Didier
Botton Gerard
Moinet Gerard
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of UY27766A1 publication Critical patent/UY27766A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

La presente invención se refiere a una combinación de al menos un derivado del tipo de la 5-fenoxialquil-2,4-tiazolidindiona, administrada en forma simultánea o consecutiva, para el tratamiento de la diabetes.The present invention relates to a combination of at least one derivative of the 5-phenoxyalkyl-2,4-thiazolidinedione type, administered simultaneously or consecutively, for the treatment of diabetes.

UY27766A 2002-04-30 2003-04-15 COMBINATION OF INSULIN AND A THIAZOLIDINDIONA DERIVATIVE AND USE OF THE SAME TO TREAT DIABETES UY27766A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0205466A FR2838968A1 (en) 2002-04-30 2002-04-30 ASSOCIATION OF INSULIN AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR TREATING DIABETES

Publications (1)

Publication Number Publication Date
UY27766A1 true UY27766A1 (en) 2003-05-30

Family

ID=28800099

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27766A UY27766A1 (en) 2002-04-30 2003-04-15 COMBINATION OF INSULIN AND A THIAZOLIDINDIONA DERIVATIVE AND USE OF THE SAME TO TREAT DIABETES

Country Status (4)

Country Link
AU (1) AU2003226768A1 (en)
FR (1) FR2838968A1 (en)
UY (1) UY27766A1 (en)
WO (1) WO2003092726A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU724989B2 (en) * 1995-08-10 2000-10-05 Warner-Lambert Company A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
FR2749583B1 (en) * 1996-06-07 1998-08-21 Lipha NOVEL SUBSTITUTED THIAZOLIDINE -2,4- DIONE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
CN1230171C (en) * 1997-06-18 2005-12-07 史密丝克莱恩比彻姆有限公司 Treating diabetes by thiazolidine-diketo and dimethylbiguanide
PE20010580A1 (en) * 1999-09-03 2001-05-25 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION TO TREAT DIABETES

Also Published As

Publication number Publication date
WO2003092726A1 (en) 2003-11-13
AU2003226768A1 (en) 2003-11-17
FR2838968A1 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
PA8637201A1 (en) DIFENYLIMIDAZOPIRIMIDINE E-IMIDAZOL AMINAS AS INHIBITORS OF B-SECRETASE
HK1121074A1 (en) Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione
CL2008001821A1 (en) Imidazo [2,1-b] -thiazole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of diabetes, metabolic syndrome, insulin resistance, among others.
PA8637301A1 (en) DERIVATIVES OF AMINO-5, 5-DIFENYLIMIDAZOLONE FOR THE INHIBITION OF THE B-SECRETASE
CY1114703T1 (en) PHARMACEUTICAL COMPOSITION OF INCLUSIVE (1S) -1,5-ANHYRO-1- [5- (4-Ethoxybenzyl) -2-Methoxy-4-Methylphenyl] -1-Sulfuryl
CY1117603T1 (en) LIXISENATIDE AS AN ADDITION TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES
NO20074824L (en) Extension of time to disease progression or survival in cancer patients
AR057643A1 (en) LACOSAMIDE FOR ATTACHED THERAPY
GT200600046A (en) COMBINATION THERAPY
CL2007002890A1 (en) Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
AR045870A1 (en) COMBINATION THERAPY FOR HEPATITIS C VIRUS INFECTION
UY28005A1 (en) INDOL -3-CARBOXAMIDS AS GLUCOQUINASE ACTIVATORS (GK)
CR10166A (en) USE OF BENZO-FUSION HETEROCICLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF BIPOLAR DISORDER AND MANIA
DOP2009000165A (en) DERIVATIVES OF REPLACED OXINDOL, MEDICATIONS THAT UNDERSTAND AND USE THEMSELVES
CL2007000595A1 (en) Piperidine derived compounds; Pharmaceutical composition and use for the treatment and / or prophylaxis of diseases selected from hypertension, congestive heart failure and renal failure, among others.
AR058173A1 (en) USE OF SDF-1 FOR THE TREATMENT AND / OR PREVENTION OF NEUROLOGICAL DISEASES
CL2017002293A1 (en) Treatment of patients with type 2 diabetes mellitus
CO6311083A2 (en) 4 - ((1R, 3S) -6-CHLORO-3-FENILINDAN-1-IL) -1,2,2-TRIMETHYLIPIPERAZINE FOR THE TREATMENT OF COGNITIVE DYSFUNCTION
ECSP045397A (en) 6-ALQUILIDEN-BICYCLIC PENEMS AS INHIBITORS OF THE B-LACTAMASES
CL2009001089A1 (en) Indole-derived compounds [2,1-a] [2] benzacepin; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
AR043327A1 (en) USE OF QUINURENINE 3- HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES
UY27733A1 (en) CYCLOPENTENE DERIVATIVES
UY30557A1 (en) TREATMENT AND PREVENTION OF INTESTINAL FIBROSIS
UY27766A1 (en) COMBINATION OF INSULIN AND A THIAZOLIDINDIONA DERIVATIVE AND USE OF THE SAME TO TREAT DIABETES
NO20080495L (en) PEG-IFN-alpha and ribavirin for HBV treatment

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150430